Literature DB >> 8762169

Behavioral studies on rats with transient cerebral ischemia induced by occlusion of the middle cerebral artery.

N Sakai1, K Yanai, J H Ryu, H Nagasawa, T Hasegawa, T Sasaki, K Kogure, T Watanabe.   

Abstract

The behavioral effects of transient cerebral ischemia in adult Wistar rats were studied. In Experiment 1, rats were subjected to 90-min occlusion of the unilateral, left or right, middle cerebral artery (MCA) followed by recirculation. The locomotor activity had not changed 3 and 30 days after the occlusion, except that the number of rearing was significantly decreased by left MCA occlusion. Rats were examined in a radial maze system for learning and memory ability during 4 weeks from the 3rd day after ischemia (the 3rd day was counted as day 1 of the experiment). Maze performance was slightly disturbed due to focal brain damage by MCA occlusion, but the disturbance was statistically significant only on days 6, 11, and 15 in the right occlusion. In Experiment 2, rats were trained to master a radial maze task completely for 4 weeks, and then subjected to transient unilateral (right) ischemia as described above. These rats showed an increase in incorrect entry in the radial maze task from day 4 to day 14. However, on day 21, the number of incorrect entry decreased to the control level of the sham-operated group. The numbers of correct choice were inversely related with those of incorrect entry, though slightly blunted. Coincidentally, the time required to solve the maze task was also prolonged from day 4 to day 14, but returned to the control time on day 21. These results suggest that unilateral ischemia transiently suppresses both acquiring radial maze performance and maintenance of learned performance and that it is a good model for studying human focal cerebral ischemia.

Entities:  

Mesh:

Year:  1996        PMID: 8762169     DOI: 10.1016/0166-4328(95)00232-4

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice.

Authors:  Richard D Ronca; Alyssa M Myers; Doina Ganea; Ronald F Tuma; Ellen A Walker; Sara Jane Ward
Journal:  Life Sci       Date:  2015-05-30       Impact factor: 5.037

Review 2.  Animal Models of Vascular Cognitive Impairment and Dementia (VCID).

Authors:  Jennifer Gooch; Donna M Wilcock
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

3.  Association between changes in weight and cerebral arteries in rats.

Authors:  Afshin A Divani; Ankur Patel; Vance L Fredrickson; Blake Siljander; Gabriela Vazquez
Journal:  Transl Stroke Res       Date:  2010-03-02       Impact factor: 6.829

4.  Melatonin ameliorates injury and specific responses of ischemic striatal neurons in rats.

Authors:  Yuxin Ma; Qiqi Feng; Jing Ma; Zhibo Feng; Mali Zhan; Lisi Ouyang; Shuhua Mu; Bingbing Liu; Zhuyi Jiang; Yu Jia; Youlan Li; Wanlong Lei
Journal:  J Histochem Cytochem       Date:  2013-05-16       Impact factor: 2.479

Review 5.  Of mice and men: modelling post-stroke depression experimentally.

Authors:  G Kronenberg; K Gertz; A Heinz; M Endres
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

6.  Long-term post-stroke changes include myelin loss, specific deficits in sensory and motor behaviors and complex cognitive impairment detected using active place avoidance.

Authors:  Jin Zhou; Jian Zhuang; Jie Li; Evelyn Ooi; Jonathan Bloom; Carrie Poon; Daniel Lax; Daniel M Rosenbaum; Frank C Barone
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

7.  Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke.

Authors:  Ji Yun Ahn; Bing Chun Yan; Joon Ha Park; Ji Hyeon Ahn; Dae Hwan Lee; In Hye Kim; Jeong-Hwi Cho; Bai Hui Chen; Jae-Chul Lee; Young Shin Cho; Myoung Chul Shin; Jun Hwi Cho; Seongkweon Hong; Moo-Ho Won; Sung Koo Kim
Journal:  Exp Ther Med       Date:  2015-10-13       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.